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INTRODUCTION
Although glutamate (Glu) is one of the most im-
portant excitatory neurotransmitters, it is a known neu-
rotoxin in high concentration. Normally it is present in
low concentrations in the extracellular space of normal
brain. During and after ischemia, Glu is released from
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neurons and astrocytes in excessive quantities through
excitatory Glu amino acid receptors such as N-methyl-
D-aspartate (NMDA), a cascade of events will lead to
cell death (1-5). Glycine (Gly) in the cerebrum is an
important facilitator of Glu's action through an allosteric
site on the NMDA receptor (6,7). Gly is also increased
after global ischemia (8). Mild hypothermia (MHT) in-
hibits the release of both Glu and Gly during global
ischemia (8-10). However, the effect of MHT on the
release of Glu and Gly at different time points during
the ischemic and reperfusion periods has not been well
investigated.
The purpose of this study is to determine the effects
of MHT (32°C) during periods of ischemia (MHTi), re-
perfusion (MHTr), and ischemia/reperfusion (MHTi +
The present study is to determine the effect of mild hypothermia (MHT) on the release of glutamate
and glycine in rats subjected to middle cerebral artery occlusion and reperfusion. The relationship
between amino acid efflux and brain infarct volume was compared in different periods during
MHT. Reversible middle cerebral artery occlusion was performed in Sprague-Dawley rats using a
suture model. The rats were divided into four groups including (1) MHT during ischemia (MHTi),
(2) MHT during reperfusion (MHTr), (3) MHT during ischemia and reperfusion (MHTi + r), and
(4) a normothermic group (NT). Extracellular concentrations of glutamate and glycine in the cortex
and striatum were monitored using in vivo microdialysis and analyzed using high-performance
liquid chromatography. Morphometric measurements for infarct volume were performed using
2,3,5-triphenyltetrazolium chloride staining. The increase of glutamate and glycine in the ischemic
cortex of the MHTi and MHTi + r rats during ischemic and reperfusion periods was significantly
less than that of the NT rats (p < 0.05). However, there was no statistical difference among these
groups in the peak of glutamate and glycine release in the striatum. Infarct volume paralleled the
release of glutamate and glycine. The protective effect of MHTi and MHTi + r in reducing
ischemia and reperfusion brain injury may be due to the attenuation of both glutamate and glycine
release during ischemia and reperfusion.
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r) on the release of Glu and Gly in the ischemic cortex
and striatum in the rats subjected to 3 hr of middle ce-
rebral artery occlusion (MCAO) followed by 3 hr of re-
perfusion.
EXPERIMENTAL PROCEDURE
Animal Preparation. Procedures using laboratory animals were
approved by the Institutional Animal Care and Use Committee. Forty-
eight male Sprague-Dawley rats weighing 280 to 310 grams were
used. The rats were fasted overnight before the day of the experiment
but were allowed free access to tap water. Rats were anesthetized with
1.5% isoflurane in 70%N2O/30%O2 gas mixture and ventilated to
maintain PaO2 at 90 mmHg or above. A PE-50 catheter was introduced
into the femoral artery for continuous monitoring of arterial blood
pressure and blood sampling of gases and glucose concentrations.
Blood samples were assayed three times during the experiment (5 min
before, 90 min after ischemia, and 90 min after reperfusion). A ther-
mocouple (400 Series, YSI Co Inc. USA) was placed in the rectum.
Body temperature was maintained at 32°C or 37°C with a feedback-
controlled heating and cooling system (MTA 4703, Medi-Therm Gay-
mar Inc. USA).
Experimental Protocols. Rats were subjected to 3 hr of MCAO
followed by 3 hr of reperfusion. The MCAO method used has been
described previously (11). Rats were divided into four groups, twelve
rats in each group (6 cortex and 6 striatum microdialysis, respectively).
In the normothermic (NT) group the brain and body temperature was
kept at 37°C during ischemia and reperfusion. In the MHTr group the
brain and body temperature were maintained at 37°C during ischemia,
and reduced to 32°C during reperfusion. In the MHTi group the brain
and body temperature was reduced to 32°C during MCAO and restored
to 37°C during reperfusion. In the MHTi + r group the brain and body
temperature was maintained at 32°C throughout the experiment. Samples
of extracellular fluid in the cortex and striatum were collected by intra-
cerebral microdialysis during the 3 hr ischemic and the 3 hr reperfusion
period, and analyzed by a high-performance liquid chromatography
(HPLC) system. After each experiment, the animals were sacrificed and
their brains removed immediately for measuring infarct volume.
Measurement and Stabilization of Brain Temperature. Epidural
temperature was very close to the ipsilateral brain temperature in our
previous study (data not show here). A small burr hole was made at
3 mm lateral and 2 mm posterior to the bregma for monitoring epidural
temperature. Dura was separated gently from the calvarium, and a
thermocouple (E-type, Omega Engineering Inc., Stanford, CT, USA)
was inserted into the epidural space and fixed with dental cement. The
epidural temperature was kept constant at 37°C in the NT rats. The
epidural temperature was kept constant at 32°C during the period of
MHT in the MHTi, MHTr, MHTi + r group rats.
Microdialysis. A microdialysis probe (ESA 0398, Tip length 2
mm, Tip diameter 0.45 mm, ESA Inc. USA) was stereotactically im-
Fig. 1. Line graph shows mean ± SEM corrected dialysate concentration of glutamate and glycine in the MCA territory followed by 3 hr of
MCAO and 3 hr of reperfusion. Fig. 1A: Local Glu was measured at the ischemic striatum, 1B: Local Glu was measured at the ischemic cortex,
1C: Local Gly was measured at the ischemic striatum, and 1D: Local Gly was measured at the ischemic cortex. Sham = normal control rats; NT
= normothermic rats; MHT = mild hypothermia; (i) = ischemia; (r) = reperfusion; and (i + r) = ischemia and reperfusion. Data are mean ±
SEM for 6—8 rats in each group.
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Fig. 2. Bar graph showing infarct volumes following 3 hr MCAO and
3 hr reperfusion. Data are mean ± SEM for 6-8 rats in each group.
NT = normothermic rats; MHT = mild hypothermia; (r) = reperfu-
sion; (i) = ischemia; and (i + r) = ischemia and reperfusion. *p <
0.05; MHTi and MHTi + r vs. NT group rats.
planted from point A 0.7 mm anterior, 3.5 mm lateral, and 2.0 mm
ventral to the bregma into the ischemic cortex and point B 0.7 mm
anterior, 5.5 mm lateral, and 5.0 mm ventral to the bregma into the
striatum (12). After implantation of the probe the animal was main-
tained under light anesthesia (0.5-1.0% isoflurane flow) for 2 hr as a
control stabilization period before the introduction of ischemia. Each
probe was perfused with artificial cerebrospinal fluid (147 mM NaCl,
2.3 mM CaCl2, 0.9 mM MgCl2, 4.0 mM KCl) at a rate of 2 Ml/min
by a microinfusion pump (CMA-100, Carnegie Medicin, Sweden). Di-
alysate samples were obtained at 20 min intervals and collected in
sampling tubes in an ice bath (CMA-170, CMA Co. Sweden). Two
baseline samples were collected before the ischemic insult. All sam-
ples were frozen immediately and stored at -25°C until analysis. The
dialysates from cortex and striatum were analyzed using HPLC with
phenylisothiocyanate derivation on a reverse phase C-18 column. De-
rivatives were detected fluorometrically, and peak areas were inte-
grated and quantified based on linear calibration with known amino
acid standards. This method has been shown to be sensitive to low-
picomolar-range concentration of amino acids (13).
Morphometric Measurement of Infarct Volume. Brains were re-
moved immediately following 72 hr ischemic insult. Six coronal slices
2, 4, 6, 8, 10, and 12 mm distal from the frontal pole were dissected
using a brain slicer. All slices were incubated by immersion in 2%
2,3,5,-triphenyltetrazolium chloride (TTC) solution for 20 min at 37°C.
The area of infarction in each slice was analyzed by a computerized
image analysis system (Medical Image Processing System, FG-100
Series, Imaging Technology Inc. USA). The infarct volume was cal-
culated by summing the products of distance between sections and the
infarct areas.
Statistical Analysis. Analysis of variance was used to determine
the statistical significance of differences in neuronal damage volumes
and physiological variables among the four treatment groups. Multi-
vanate analysis of variance was used to compare Glu and Gly con-
centrations. Correlation between amino acid efflux and infarct volume
was determined using linear regression analysis. All values are ex-
pressed as the mean ± SEM, and differences were considered signif-
icant at p < 0.05.
RESULTS
Physiological Variables. All physiological param-
eters including arterial pressure, blood gases and glucose
were within the normal range throughout the experi-
ments. There were no statistically significant differences
among the four groups (data is not shown here). These
data indicate that MHT does not substantially change
these physiological parameters.
Glutamate and Glycine. The time course of changes
in concentrations of Glu and Gly in the dialysate of the
striatum and cortex are illustrated in Figs. 1A-D. There
was no difference among the four groups in the dialysate
concentrations of Glu and Gly before ischemia. In all
four groups, the ischemic episodes resulted in significant
elevations of extracellular concentrations of Glu and Gly
in both the striatum and cortex. However, the peak con-
centrations of Glu and Gly in the cortex of MHTi + r
and MHTi rats were significantly lower than that of NT
rats (Glu: MHti + r vs NT, 1272 ± 211 nM vs 2526
± 578 nM, p < 0.05; MHTi vs NT, 1389 ± 158 nM
vs 2526 ± 578 nM, p < 0.05. Gly: MHTi + r vs NT,
2095 ± 281 nM vs 3521 ± 631 nM, p < 0.05; MHTi
vs NT, 2181 ± 377 vs 3521 ± 631 nM, p < 0.05).
There was no significant difference in peak concentra-
tions of Glu and Gly in the striatal dialysate among the
four groups. The level of Glu in the cortex of MHTi +
r rats returned to the baseline of preischemia following
reperfusion while during reperfusion it was still higher
in NT rats (p < 0.05). The levels of Gly in both striatum
and cortex regions of MHTi + r and MHTi rats were
significantly lower than that of the NT rats (p < 0.05).
The levels of Glu and Gly in the MHTr group appeared
lower than that of NT group, however there was no sta-
tistically significant difference (p < 0.05). The level of
Gly in the cortical dialysate of the MHTi rats was sig-
nificantly higher than that of the MHTi + r rats follow-
ing 1 hr of reperfusion (p < 0.05).
Infarct Volume. The mean total infarct volumes in
both the MHTi and MHTi + r groups were significantly
smaller than that of the NT group (MHTi 100 ± 63 vs.
226 ± 42 mm3, p < 0.01; MHTi + r 85 ± 52 vs. 226
± 42 mm3, p < 0.01). In both the MHTi and MHTi +
r groups the infarct nidus was located mainly in the basal
ganglia region whereas in the MHTr and NT groups,
both basal ganglia and cortex were involved. It was no-
ticed that the mean infarct volume in the MHTi + r
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Fig. 3. Scatterplot shows relation between infarct volume changes and Glu concentration in the ischemic striatum (3A) and cortex (3B), as well
as infarct volume changes and Glu concentration in the ischemic striatum (3C) and cortex (3D) followed by 3 hr of MCAO and 3 hr of reperfusion.
group was slightly smaller than that of the MHTi group,
however, there was no statistical difference (p > 0.05,
Fig. 2).
Correlation of Glu and Gly with Infarct Volume.
The peak concentrations of Glu and Gly in both striatal
and cortical dialysates were correlated with the total in-
farct volume of individual rats (Fig. 3A-D). A strong
positive correlation between peak concentrations of Glu
and Gly in the ischemic striatum and infarct volume
were found (Glu: r = 0.85, p < 0.01; Gly: r = 0.89, p
< 0.01). These results indicate that the increase of Glu
and Gly concentrations significantly worsened ischemic
brain injury.
DISCUSSION
Considerable evidence has now accumulated from
both in vitro and in vivo experiments that Glu plays an
important role in the evolution of ischemic brain dam-
age. There is evidence that an increase of extracellular
Glu is an important mediator causing ischemic neuronal
injury (14). Thus, any intervention that results in inhib-
iting the release of Glu may be expected to reduce the
severity of ischemic brain injury. The present study
demonstrated that MHTi and MHTi + r markedly in-
hibited the release of Glu and Gly in both ischemic stria-
tum and cortex during focal ischemia and reperfusion.
Furthermore, the protective effect of MHTi + r on in-
hibiting the release of Gly was greater than that of MHTi
following reperfusion. Previous investigations have
shown that MHTi attenuates the release of both Glu and
Gly during global ischemia (8,9,10,15). The present re-
sults are similar to those found in rats subjected to tran-
sient focal ischemia. The release of Glu and Gly returned
to the baseline range rapidly at the end of global isch-
emia. However, the concentration of Glu and Gly was
sustained at even higher levels following 3 hr ischemia
and 3 hr reperfusion. These results indicated that the
release of Glu and Gly in the striatum is significantly
higher than in the cortex suggesting the effects of MHTi
on inhibiting the release of Glu and Gly in cortex and
striatum are different. In the cortex, the peak and sus-
tained concentrations of Glu and Gly in the MHTi group
were significantly lower than that in the NT group. How-
ever, no statistical difference was found in peak concen-
trations of Glu and Gly in the striatum between MHTi
and NT groups. The striatum may represent the "isch-
emic core" with minimal post occlusion blood flow
since this area is supplied exclusively by lenticulostriate
end arteries. In contrast, the cortex may represent an
"ischemic penumbra" since some blood flow may persist
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through collateral supply (16-18). Ischemia induced re-
lease of Glu and Gly is believed to be the result of en-
ergy substrate depletion, which is closely related to
reduction in regional blood flow (19). This leads to a
Ca2+-dependent efflux of neurotransmitter amino acids
(20), as well as a reversal of the uptake carrier and in-
hibition of the neurotransmitter uptake systems in glia
for Glu (21). The less severe reduction of blood flow in
the cortex would be expected to produce a less pro-
nounced efflux of Glu and Gly.
Extracellular concentrations of Glu in the brain de-
pend upon the balance between release and uptake of
Glu. In the normal situation, Glu is released from nerve
terminals and then taken up by nerve terminals and glial
cells. The extracellular concentration of Glu is very low.
During ischemia, however, the extracellular Glu rises to
a neurotoxic level (22,23). Szatkowski and Katayama
demonstrated that the release of Glu is increased and the
uptake system is disrupted (24,25). The effect of MHTi
+ r on inhibiting the release of Glu during focal cerebral
ischemia and reperfusion has not been well investigated
previously. Similar to the MHTi group of animals, Glu
and Gly efflux in the ischemic hemisphere were ob-
served in MHTi + r rats during the ischemic period.
However, following one hr of reperfusion the effect of
MHTi + r on inhibiting the release of Gly in the cortex
was greater than that of MHTi. Persistent elevation of
Gly during the postischemic period may explain the ap-
parent ongoing toxicity of Glu (8). The efficiency of
MHTi + r to inhibit a sustained elevation of Gly release
in the cortex may help to explain the better effect of
MHTi + r in reducing infarct volume than other groups.
It may reflect an important component of the protective
mechanism of hypothermia. Since the mechanisms of
Gly release and uptake have not been fully elucidated,
further studies are needed to identify the reactions that
mediate the release and uptake of Gly by MHTi and
MHTi + r.
Conclusion. Our result demonstrated that the infart
volume parallels the release of Glu and Gly. The effects
of MHTi and MHTi + r on reducing ischemic and re-
perfusion injury is attributed to their action on reducing
both extracellular Glu and Gly concentrations during fo-
cal cerebral ischemic and reperfusion.
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